Our system has noticed that you are based in , but the current country setting is . Select country

Press Photos

Please note our terms of use governing the use of press images.By downloading the images from our media database, you agree to these terms of use: Press images may only be used for press purposes (print, electronic media, online) and exclusively in the context of the associated press release and may not be edited. The picture credits (source: Wacker Chemie AG) are mandatory. Images deleted from the media database may no longer be used in the future. If a press photo is used, a copy of the publication or a link to the publication is requested. Otherwise, the copyright information www.wacker.com/disclaimer applies.

Vaccines: Fill & Finish

From development to dispensing: at the Amsterdam site, vaccines can be dispensed into their final packaging for shipment to the customer. The vials then undergo one last quality check (photo: WACKER).

(JPG, 829 KB) Download picture

Vaccines: Fermenter

In stainless steel tanks known as fermenters, bacteria at Wacker Biotech produce the desired active substances (photo: WACKER).

(JPG, 333 KB) Download picture

Vaccines: Lab

Before the large-scale production of a vaccine can begin, the first step is to develop the production process in the lab (photo: WACKER).

(JPG, 159 KB) Download picture

Producing a Conjugated Polysaccharide Vaccine

(Illustration: WACKER)

(JPG, 302 KB) Download picture

Wacker Biotech Dr. Susanne Leonhartsberger

Dr. Susanne Leonhartsberger has been the managing director of Wacker Biotech GmbH since 2017, and, in her capacity as the head of the Biopharmaceuticals business line, is responsible for WACKER’s biologics business. “What especially motivates me is that we’re providing innovative medications for sick people all over the world – and that’s how most of us feel,” the biologist observes. (Photo: Wacker Chemie AG)

(JPG, 1.4 MB) Download picture